Liver-targeted delivery of TSG-6 by calcium phosphate nanoparticles for the management of liver fibrosis
Conclusions: TSG-6 was a major antifibrotic cytokine of MSCs, TSG-6 loaded CaP@BSA NPs showed specific liver accumulation and improved therapeutic effects, which indicated translational potentials of CaP@BSA as a promising drug carrier for the liver disease management.
Source: Theranostics - Category: Molecular Biology Authors: Min Wang, Miao Zhang, Lianhua Fu, Jing Lin, Xinmin Zhou, Pinghong Zhou, Peng Huang, Hao Hu, Ying Han Tags: Research Paper Source Type: research
More News: Calcium | Cirrhosis | Genetics | Liver | Liver Disease | Liver Transplant | Molecular Biology | Nanotechnology | Stem Cell Therapy | Stem Cells | Study | Transplants | Urology & Nephrology